Loic Ysebaert

Loic Ysebaert

UNVERIFIED PROFILE

Are you Loic Ysebaert?   Register this Author

Register author
Loic Ysebaert

Loic Ysebaert

Publications by authors named "Loic Ysebaert"

Are you Loic Ysebaert?   Register this Author

100Publications

3246Reads

16Profile Views

Phase 1 first-in-human trial of the anti-CD37 antibody BI 836826 in relapsed/refractory chronic lymphocytic leukemia.

Leukemia 2019 Oct 14;33(10):2531-2535. Epub 2019 May 14.

Department of Medicine V, University Hospital Heidelberg, Department of Molecular Therapy in Haematology & Oncology, NCT/DKFZ, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0475-zDOI Listing
October 2019

Targeted therapy of BRAF V600E-mutant histiocytic sarcoma: A case report and review of the literature.

Eur J Haematol 2019 Oct 23;103(4):444-448. Epub 2019 Aug 23.

Department of Haematology, IUCT-Oncopole, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13303DOI Listing
October 2019

Venetoclax to treat relapsed blastic plasmacytoid dendritic cell neoplasm: A case-report and review of literature.

Leuk Res 2019 Oct 5;85:106199. Epub 2019 Aug 5.

Department of oncogeriatric medicine, University Hospital Purpan, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.106199DOI Listing
October 2019

Ribavirin for Chronic Hepatitis E Virus Infection in Ibrutinib-Exposed Patients.

Open Forum Infect Dis 2019 Sep 28;6(9):ofz345. Epub 2019 Jul 28.

Hematology Department, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ofid/ofz345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798245PMC
September 2019

Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia.

BMC Cancer 2019 Aug 14;19(1):809. Epub 2019 Aug 14.

Department of Haematology, Toulouse-Oncopole University Cancer Institute (IUCT-O), 1 Avenue Irene Joliot-Curie, 31059, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-019-5971-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694602PMC
August 2019

On the BALL to spot the best score able to predict overall survival in relapsed or refractory CLL.

Authors:
Loic Ysebaert

Lancet Haematol 2019 07 17;6(7):e343-e344. Epub 2019 May 17.

Service d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, 31000 Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30091-2DOI Listing
July 2019

France: The First Country to Ban a Type of Breast Implant Linked to Anaplastic Large Cell Lymphoma.

Aesthet Surg J 2019 Jul;39(8):NP352-NP353

Département de Chirurgie Plastique et de Reconstruction, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/asj/sjz142DOI Listing
July 2019

Lymphoproliferative disease in patients with Wiskott-Aldrich syndrome: Analysis of the French Registry of Primary Immunodeficiencies.

J Allergy Clin Immunol 2019 Jun 20;143(6):2311-2315.e7. Epub 2019 Feb 20.

Clinical Hematology, Necker University Hospital, AP-HP, Paris, France; Paris Descartes University, Sorbonne Paris Cité University, Imagine Institute, Paris, France; INSERM UMR1163 & CNRS URL 8254, Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutical implications, Paris, France; French National Reference Center for Primary Immune Deficiencies (CEREDIH), Necker University Hospital, AP-HP, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2019.01.046DOI Listing
June 2019

Dose-limiting stomatitis associated with ibrutinib therapy: a case series.

Br J Haematol 2019 May 8;185(4):784-788. Epub 2018 Nov 8.

Oral Medicine Department, Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.15620
Publisher Site
http://dx.doi.org/10.1111/bjh.15620DOI Listing
May 2019

Multiparametric analysis of CD8 T cell compartment phenotype in chronic lymphocytic leukemia reveals a signature associated with progression toward therapy.

Oncoimmunology 2019 7;8(4):e1570774. Epub 2019 Feb 7.

Centre de Recherches en Cancérologie de Toulouse (CRCT), INSERM U1037, «Equipe labellisée Ligue Nationale contre le cancer 2018», Université de Toulouse III-Paul Sabatier, Toulouse, France.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/2162402X.2019.1
Publisher Site
http://dx.doi.org/10.1080/2162402X.2019.1570774DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422371PMC
February 2019

[Minimal residual disease in chronic lymphocytic leukemia: A still current issue in 2018].

Bull Cancer 2018 Nov 20;105(11):1042-1051. Epub 2018 Sep 20.

IUCT-Oncopôle, service d'hématologie clinique, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France; IUCT-Oncopôle, laboratoire d'hématologie-immunophenotypage et hematologie cellulaire, 1 avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France; CRCT, Inserm UMR 1037, 2, avenue Hubert-Curien, 31037 Toulouse cedex 1, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2018.07.008DOI Listing
November 2018

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.

N Engl J Med 2018 09;379(10):934-947

From Université Lille, Centre Hospitalier Universitaire (CHU), Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille (F.M.), CHU Régional de Nancy, Service d'Hématologie, Vandoeuvre lès Nancy (P.F.), Institut Paoli-Calmettes (R.B.) and Department of Pathology, Institut Paoli-Calmettes, Centre de Recherche en Cancerologie de Marseille, INSERM, Centre National de la Recherche Scientifique, Aix-Marseille Université (L.X.), Marseille, Centre Henri Becquerel, Unité 1245 and Département d'Hématologie, Université de Rouen, Rouen (H.T.), Institut d'Hématologie de Basse Normandie, Caen (C.F.), CHU Le Bocage Service d'Hématologie Clinique, Dijon (R.-O.C.), Hôpital Henri Mondor Unité Hémopathies Lymphoïdes, Créteil (C.H.), Centre Hospitalier Départemental Vendée Service d'Onco-Hématologie, La Roche sur Yon (H.M.), Institut Universitaire du Cancer de Toulouse Oncopole Service d'Hématologie, Toulouse (L.Y.), CHU Bordeaux, Service d'Hématologie, Bordeaux (K.B.), Hôpital Saint Louis Service d'Onco-Hématologie, Paris (P.B.), Gustave Roussy Cancer, Villejuif (V.R.), Centre Hospitalier Annecy Genevois Service, Annecy (N.D.), CHU de Nantes-Hôtel Dieu Service d'Hématologie Clinique, Centre de Recherche en Cancerologie et Immunologie, INSERM, Centre National de la Recherche Scientifique, Université de Nantes, Nantes (S.L.G.), Centre Hospitalier Métropole Savoie Service Hématologie, Chambery (G.M.P.), Department of Hematology, CHU Montpellier, University of Montpellier, Montpellier (G.C.), and Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, University of Lyon, Pierre-Benite (G.A.S.) - all in France; the Department of Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston (N.H.F.); the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (M.L.P.); the Department of Medicine, Division of Medical Oncology, University of Washington, Seattle (E.N.L.); Sarah Cannon Research Institute-Tennessee Oncology, Nashville (I.W.F.); Washington University School of Medicine, Siteman Cancer Center, St. Louis (N.L.B.); the Department of Hematology, Hospital Universitario de Salamanca and Instituto de Investigación Biomédica de Salamanca, Centro de Investigación Biomédica en Red de Cáncer, Salamanca (A.M.G.-S.), and the Department of Hematology, Hospital Clinic de Barcelona, Barcelona (A.L.-G.) - both in Spain; CHU de Québec, Hôpital de l'Enfant-Jésus, Quebec (J.-F.L.), and British Columbia Cancer Centre for Lymphoid Cancer, University of British Columbia, Vancouver (L.H.S.) - both in Canada; the Department of Hematology and Oncology, Tokai University Hospital, Kanagawa, Japan (K.A.); Instituto Português de Oncologia Lisboa Francisco Gentil Departamento de Hematologia, Lisbon (M.G.S.); the Department of Hematology, CHU Université Catholique de Louvain Namur, Yvoir (M.A.), and the Department of Hematology, Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerp (P.Z.) - both in Belgium; the Department of Hematology, National Cancer Center Hospital, Tokyo, Japan (K.T.); and Celgene, Summit, NJ (D.L., J.W.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1805104
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1805104DOI Listing
September 2018

Bendamustine plus rituximab for indolent B-cell lymphoma of renal significance.

Am J Hematol 2018 03 6;93(3):356-362. Epub 2017 Dec 6.

Département de Néphrologie et Transplantation d'organes, Centre Hospitalier Universitaire de Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24984DOI Listing
March 2018

Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia.

Hematol Oncol 2017 Dec 28;35(4):664-670. Epub 2016 Sep 28.

Service d'Hématologie Clinique, CHU de Toulouse, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France.

View Article

Download full-text PDF

Source
https://www.researchgate.net/profile/Yannick_Le_Bris/publica
Web Search
http://dx.doi.org/10.1002/hon.2349DOI Listing
December 2017

Targeting Kinases in Cancer Therapies: Adverse Effects on Blood Platelets.

Curr Pharm Des 2016 ;22(16):2315-22

Inserm U1048, I2MC, 1 Avenue Jean Poulhès, BP 84225, 31432 Toulouse Cedex 04, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612822666160226132630DOI Listing
November 2017

Asymptomatic circulating T-cell clone cause renal polymorphic inflammatory fibrosis.

Clin Exp Nephrol 2017 Oct 26;21(5):781-786. Epub 2016 Dec 26.

Département de Néphrologie et Transplantation d'organes et Centre de référence des maladies rénales rares, CHU Rangueil, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10157-016-1373-6DOI Listing
October 2017

Nurse-like cells promote CLL survival through LFA-3/CD2 interactions.

Oncotarget 2017 Aug 26;8(32):52225-52236. Epub 2016 Nov 26.

CRCT UMR1037 INSERM-ERL 5294 CNRS-Université Toulouse III Paul Sabatier, Toulouse, France.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/13660
Publisher Site
http://dx.doi.org/10.18632/oncotarget.13660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581024PMC
August 2017

Bendamustine for relapsed blastic plasmacytoid dendritic cell leukaemia.

Hematol Oncol 2017 Jun 8;35(2):252-255. Epub 2015 Oct 8.

Hematology Department, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2252DOI Listing
June 2017

Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies.

Oncotarget 2016 Dec;7(52):85937-85947

Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.13262DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349887PMC
December 2016

Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study.

Br J Haematol 2016 Nov 9;175(3):462-466. Epub 2016 Sep 9.

Service d'Hématologie Biologique, GHUPSSD, AP-HP, U978 INSERM, Université Paris 13, Sorbonne Paris Cité, Labex Inflamex, Bobigny, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14324DOI Listing
November 2016

Impaired functional responses in follicular lymphoma CD8TIM-3 T lymphocytes following TCR engagement.

Oncoimmunology 2016 24;5(10):e1224044. Epub 2016 Aug 24.

Centre de Physiopathologie de Toulouse Purpan, INSERM U1043, Toulouse, France; Département de Pathologie, Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France; Laboratoire d'Excellence "TOUCAN," Toulouse, France; Program Hospitalo-Universitaire en Cancérologie "CAPTOR," Toulouse, France; CALYM Carnot Institute, Pierre-Bénite, France; Université Toulouse III Paul-Sabatier, Toulouse, France; Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1224044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135226PMC
August 2016

Erratum to: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies.

Exp Hematol Oncol 2015 14;5:10. Epub 2016 Apr 14.

INSERM UMR1098, Établissement Français du Sang Bourgogne Franche Comté, Université de Franche-Comté, SFR FED4234, 25020 Besançon, France ; Laboratoire de Thérapeutique Immuno-Moléculaire et cellulaire des cancers, INSERM UMR1098, Etablissement Français du Sang-Bourgogne/Franche-Comté, 8, rue du Docteur Jean-François-Xavier Girod, 25020 Besançon Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40164-016-0038-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831155PMC
April 2016

New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies.

Exp Hematol Oncol 2015 1;5. Epub 2016 Mar 1.

INSERM UMR1098, Établissement Français du Sang Bourgogne Franche Comté, Université de Franche-Comté, SFR FED4234, 25020 Besançon, France ; Laboratoire de Thérapeutique Immuno-Moléculaire et cellulaire des cancers, INSERM UMR1098, Etablissement Français du Sang-Bourgogne/Franche-Comté, 8, rue du Docteur Jean-François-Xavier Girod, 25020 Besançon Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40164-016-0036-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774009PMC
March 2016

Small nucleolar RNA expression profiles refine the prognostic impact of IGHV mutational status on treatment-free survival in chronic lymphocytic leukaemia.

Br J Haematol 2016 Mar 11;172(5):819-23. Epub 2015 Jun 11.

INSERM UMR1037 CRCT/Université Toulouse III-Paul Sabatier UMR1037 CRCT/CNRS ERL5294 CRCT, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13544DOI Listing
March 2016

Management of elderly patients with chronic lymphocytic leukemia in the era of targeted therapies.

Curr Opin Oncol 2015 Sep;27(5):365-70

aService d'Hematologie, IUC-Toulouse Oncopole, Toulouse bService d'Hematologie, Hôpitaux de Brabois, Vandoeuvre Les Nancy cService d'Hématologie, Centre Hospitalier Lyon Sud, HCL, Pierre Bénite, France.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/CCO.0000000000000213DOI Listing
September 2015

L-selectin controls trafficking of chronic lymphocytic leukemia cells in lymph node high endothelial venules in vivo.

Blood 2015 Sep 10;126(11):1336-45. Epub 2015 Jul 10.

Centre National de la Recherche Scientifique, Institut de Pharmacologie et de Biologie Structurale, Toulouse, France; Université de Toulouse, Université Paul Sabatier, Toulouse, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-02-626291DOI Listing
September 2015

Several immune escape patterns in non-Hodgkin's lymphomas.

Oncoimmunology 2015 Aug 2;4(8):e1026530. Epub 2015 Apr 2.

Centre de Recherches en Cancérologie de Toulouse; INSERM UMR1037 ; Toulouse, France ; Université Toulouse III Paul-Sabatier ; Toulouse, France ; ERL 5294 CNRS ; Toulouse, France ; Programme Hospitalo-Universitaire en Cancérologie CAPTOR ; Toulouse, France ; Institut Carnot Lymphome CALYM ; Toulouse, France ; Laboratoire d'Excellence 'TOUCAN' ; Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1026530DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570141PMC
August 2015

Nurse like cells: chronic lymphocytic leukemia associated macrophages.

Leuk Lymphoma 2015 May 11;56(5):1570-2. Epub 2015 Feb 11.

INSERM UMR1037 - Cancer Research Center of Toulouse , Toulouse , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.991731DOI Listing
May 2015

Bendamustine is effective in T-cell prolymphocytic leukaemia.

Br J Haematol 2015 Mar 15;168(6):916-9. Epub 2014 Oct 15.

Service des Maladies du Sang, Centre Hospitalier Régional et Universitaire de Lille, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13175DOI Listing
March 2015

Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).

Am J Hematol 2015 Mar 16;90(3):204-7. Epub 2015 Jan 16.

CHU Reims, Hôpital Robert Debré, Service d'Hématologie Clinique, Rue du général Koenig, Reims F-51092, France; Université Reims Champagne Ardenne, UFR Médecine, 51 rue Cognac Jay, Reims F-51095, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23909DOI Listing
March 2015

Clinical activity of a new regimen combining gemcitabine and alemtuzumab in high-risk relapsed/refractory chronic lymphocytic leukemia patients.

Eur J Haematol 2015 Jan 17;94(1):37-42. Epub 2014 Sep 17.

Department of Hematology, Purpan University Hospital, Toulouse cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12391DOI Listing
January 2015

Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions.

Blood 2014 Dec 10;124(26):3991-5. Epub 2014 Oct 10.

INSERM, U1048 and Université Toulouse 3, Institut des Maladies Métaboliques et Cardiovasculaires, Toulouse, France; Laboratoire d'Hématologie Centre Hospitalier Universitaire de Toulouse, Toulouse, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-06-583294DOI Listing
December 2014

Bruton's tyrosine kinase inhibitors: lessons learned from bench-to-bedside (first) studies.

Curr Opin Oncol 2014 Sep;26(5):463-8

aDepartment of Hematology, IUC Toulouse-Oncopole, and Cancer Research Center of Toulouse (CRCT), INSERM UMR1037-CNRS ERL5294, Toulouse bService d'Hématologie, Centre Hospitalier Lyon Sud, Pierre Bénite, France.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/co-oncology/2014/09000/Bruton_s
Web Search
http://dx.doi.org/10.1097/CCO.0000000000000114DOI Listing
September 2014

Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemia.

Br J Haematol 2014 Aug 18;166(3):390-400. Epub 2014 Apr 18.

Caen University Hospital, Laboratory of Haematology, Caen, France; University of Caen, Medical School, EA4652, Caen, France; Caen University Hospital, Regional Registry of Malignant Haemopathies of Lower-Normandy, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12908DOI Listing
August 2014

Images in clinical medicine. Disseminated cryptococcosis.

N Engl J Med 2014 May;370(18):1741

Toulouse University Hospital, Toulouse, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMicm1309435DOI Listing
May 2014

Recombinant human IL-15 trans-presentation by B leukemic cells from chronic lymphocytic leukemia induces autologous NK cell proliferation leading to improved anti-CD20 immunotherapy.

J Immunol 2013 Oct 30;191(7):3634-40. Epub 2013 Aug 30.

INSERM Unité Mixte de Recherche 1037, Cancer Research Center of Toulouse, BP3028 Centre Hospitalier de l'Université Purpan, F-31300 Toulouse, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1300187DOI Listing
October 2013

T cells in CLL: lost in migration.

Authors:
Loic Ysebaert

Blood 2013 Apr;121(14):2580-2

INSERM UMR1037, Centre de Recherches sur le Cancer de Toulouse.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-01-480384DOI Listing
April 2013

First immunochemotherapy outcomes in elderly patients with CLL: a retrospective analysis.

J Geriatr Oncol 2013 Apr 26;4(2):141-7. Epub 2013 Feb 26.

Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Department of Hematology, 165 chemin du grand revoyet, 69495 Pierre Bénite, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2013.01.002DOI Listing
April 2013

What lessons can be learned from γδ T cell-based cancer immunotherapy trials?

Cell Mol Immunol 2013 Jan 17;10(1):35-41. Epub 2012 Dec 17.

INSERM UMR1037-Cancer Research Center of Toulouse, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/cmi.2012.39DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003170PMC
January 2013

[Chronic lymphoid leukaemia].

Rev Prat 2013 Jan;63(1):113-7

Service d'hématologie, CHU Purpan, 31059 Toulouse Cedex 9, France.

View Article

Download full-text PDF

Source
January 2013

[Conventional therapeutic strategies for relapsed chronic lymphocytic leukemia].

Bull Cancer 2012 Dec;99(12):1123-32

Inserm CIC-501, EA7283, CHU Estaing, université d'Auvergne, service d'hématologie clinique adultes et de thérapie cellulaire, 1, place Lucie-Aubrac, 63000 Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2012.1673DOI Listing
December 2012

Effectiveness of telephone support during chemotherapy in patients with diffuse large B cell lymphoma: the Ambulatory Medical Assistance (AMA) experience.

Int J Nurs Stud 2011 Aug 23;48(8):926-32. Epub 2011 Feb 23.

Service d'hématologie clinique, CHU Purpan, 1 place du Dr. Baylac, F-31300 Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijnurstu.2011.01.008DOI Listing
August 2011

Enzastaurin hydrochloride for lymphoma: reassessing the results of clinical trials in light of recent advances in the biology of B-cell malignancies.

Expert Opin Investig Drugs 2011 Aug 5;20(8):1167-74. Epub 2011 Jun 5.

Department of Haematology, Hoˆpital Claude Huriez, CHRU, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2011.590130DOI Listing
August 2011

Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia.

Leuk Lymphoma 2011 Jul;52(7):1401-3

Hospices Civils de Lyon, Department of Hematology, Lyon-Sud University Hospital, Pierre-Bénite, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.591005DOI Listing
July 2011

Genomic and phenotypic characterization of nurse-like cells that promote drug resistance in chronic lymphocytic leukemia.

Leuk Lymphoma 2011 Jul;52(7):1404-6

Inserm U1037, Université Toulouse 3-ERL CNRS, CHU Purpan, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.568078DOI Listing
July 2011

Cancer stem cells of differentiated B-cell malignancies: models and consequences.

Cancers (Basel) 2011 Mar 25;3(2):1566-79. Epub 2011 Mar 25.

INSERM, UMR1037-Cancer Research Center of Toulouse, 31300 Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers3021566DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757378PMC
March 2011

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study.

Blood 2011 Feb 1;117(6):1834-9. Epub 2010 Dec 1.

Service d'Hématologie et de Thérapie Cellulaire, Centre Hospitalier Universitaire (CHU) Limoges, Université et Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 6101, Limoges, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-09-307454DOI Listing
February 2011

Hepatitis E virus excretion can be prolonged in patients with hematological malignancies.

J Clin Virol 2010 Oct 1;49(2):141-4. Epub 2010 Aug 1.

Service d'Hématologie, CHU de Toulouse, Hôpital Purpan, Place du Dr Baylac, 31059 Toulouse cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2010.06.016DOI Listing
October 2010

Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis.

J Clin Oncol 2009 Sep 27;27(25):4211-6. Epub 2009 Jul 27.

L'Institut National de la Santé et de la Recherche Médicale, U.563, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2008.21.5020
Publisher Site
http://dx.doi.org/10.1200/JCO.2008.21.5020DOI Listing
September 2009

Characterization of bone marrow lymphoid infiltrates after immunochemotherapy for follicular lymphoma.

Am J Clin Pathol 2007 Dec;128(6):974-80

INSERM, U.563, Physiopathology Center of Toulouse-Purpan, Paul-Sabatier University, and Department of Pathology, CHU Purpan, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/LREBX069UXDYMBXVDOI Listing
December 2007

Cell adhesion regulates CDC25A expression and proliferation in acute myeloid leukemia.

Cancer Res 2006 Jul;66(14):7128-35

Centre de Physiopathologie Toulouse-Purpan, Institut National de la Sante et de la Recherche Medicale U563-IFR30, Département "Oncogenèse et Signalisation dans les cellules hématopoïétiques," Purpan, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-2552DOI Listing
July 2006

Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis.

Cancer Res 2004 May;64(9):3191-7

Institut National de la Santé et de la Recherche Médicale Unité 563, Département d'Oncogenèse et Signalisation Cellulaire dans les Cellules Hématopoïétiques, Institut Fédératif de Recherche (IFR)30, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.can-03-3005DOI Listing
May 2004